CTC Bio (060590) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for CTC Bio is dated 2025-01-23; the most recent is 2025-10-27. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea).
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-10-27 | BUY | 장외매수 | 바이오노트 bionote | - | 2.6M | ₩5,340 | -18.9% | ₩13.7B ($9.5M) |
| 2025-10-27 | SELL | 장외매도 | 파마리서치 Pharma Research | - | -2.6M | ₩5,340 | +18.9% | ₩13.7B ($9.5M) |
| 2025-04-15 | BUY | 장외매수 | 파마리서치 Pharma Research | - | 700.0K | ₩7,100 | -39.0% | ₩5.0B ($3.5M) |
| 2025-04-15 | BUY | 시간외매매 | 파마리서치 Pharma Research | - | 252.7K | ₩7,100 | -39.0% | ₩1.8B ($1.2M) |
| 2025-04-10 | BUY | 장외매수 | 바이오노트 bionote | - | 763.7K | ₩6,630 | -34.7% | ₩5.1B ($3.5M) |
| 2025-04-10 | BUY | 장외매수 | 바이오노트 bionote | - | 812.0K | ₩6,630 | -34.7% | ₩5.4B ($3.7M) |
| 2025-01-23 | BUY | 장외매수 | 바이오노트 bionote | - | 1.4M | ₩7,440 | -41.8% | ₩10.6B ($7.4M) |
| 2025-01-23 | SELL | 장외매도 | 이민구 Lee Min-gu | - | -1.4M | ₩7,440 | +41.8% | ₩10.6B ($7.4M) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for CTC Bio. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.